133 related articles for article (PubMed ID: 30942126)
1. Analysis of pulmonary hypertension patient survival after treatment in referral center (data of first Ukrainian register).
Radchenko GD; Zhyvylo IO; Sirenko YM
Pulm Circ; 2019; 9(2):2045894019845604. PubMed ID: 30942126
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Insights from a referral center in Portugal.
Santos M; Gomes A; Cruz C; Rocha J; Ricardo M; Gonçalves F; Carvalho L; Vicente M; Melo A; Reis A
Rev Port Cardiol (Engl Ed); 2018 Sep; 37(9):749-757. PubMed ID: 30144959
[TBL] [Abstract][Full Text] [Related]
3. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
[No Abstract] [Full Text] [Related]
4. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
Weatherald J; Boucly A; Chemla D; Savale L; Peng M; Jevnikar M; Jaïs X; Taniguchi Y; O'Connell C; Parent F; Sattler C; Hervé P; Simonneau G; Montani D; Humbert M; Adir Y; Sitbon O
Circulation; 2018 Feb; 137(7):693-704. PubMed ID: 29070502
[TBL] [Abstract][Full Text] [Related]
5. Real-world, long-term survival of incident patients with pulmonary arterial hypertension.
Marques-Alves P; Baptista R; Marinho da Silva A; Pêgo M; Castro G
Rev Port Pneumol (2006); 2017; 23(3):124-131. PubMed ID: 28283462
[TBL] [Abstract][Full Text] [Related]
6. [Value of cardiopulmonary exercise testing in comparing cardio-pulmonary function among patients with three kinds of pulmonary artery hypertension].
Zhao Q; Liu Z; Ma X; Zhao Z; Luo Q; Gu Q; Xiong C; Zhang H; Wang Y
Zhonghua Yi Xue Za Zhi; 2015 Nov; 95(44):3598-601. PubMed ID: 26813372
[TBL] [Abstract][Full Text] [Related]
7. Changed hemodynamics in acute vasoreactivity testing: prognostic predictors in chronic thromboembolic pulmonary hypertension.
Yu YZ; Yuan P; Yang YL; Sun YY; Zhao QH; Wang L; Jiang R; Wu WH; He J; Dai JH; Li Y; Pudasaini B; Li JL; Gong SG; Xie WP; Liu JM
Am J Transl Res; 2020; 12(3):959-973. PubMed ID: 32269727
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary artery dilatation correlates with the risk of unexpected death in chronic arterial or thromboembolic pulmonary hypertension.
Żyłkowska J; Kurzyna M; Florczyk M; Burakowska B; Grzegorczyk F; Burakowski J; Wieteska M; Oniszh K; Biederman A; Wawrzyńska L; Szturmowicz M; Fijałkowska A; Torbicki A
Chest; 2012 Dec; 142(6):1406-1416. PubMed ID: 22797193
[TBL] [Abstract][Full Text] [Related]
9. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
Benza RL; Miller DP; Gomberg-Maitland M; Frantz RP; Foreman AJ; Coffey CS; Frost A; Barst RJ; Badesch DB; Elliott CG; Liou TG; McGoon MD
Circulation; 2010 Jul; 122(2):164-72. PubMed ID: 20585012
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Outcomes in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS).
Kolstad KD; Li S; Steen V; Chung L;
Chest; 2018 Oct; 154(4):862-871. PubMed ID: 29777655
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in pulmonary arterial hypertension with Dana Point group 1.
Adachi S; Hirashiki A; Nakano Y; Shimazu S; Murohara T; Kondo T
Life Sci; 2014 Nov; 118(2):404-9. PubMed ID: 24632476
[TBL] [Abstract][Full Text] [Related]
12. Circulating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary Hypertension.
Richter MJ; Tiede SL; Sommer N; Schmidt T; Seeger W; Ghofrani HA; Schermuly R; Gall H
PLoS One; 2016; 11(11):e0165982. PubMed ID: 27802345
[TBL] [Abstract][Full Text] [Related]
13. Right atrial function for the prediction of prognosis in connective tissue disease-associated pulmonary arterial hypertension: a study with two-dimensional speckle tracking.
Bai Y; Yang J; Liu J; Ning H; Zhang R
Int J Cardiovasc Imaging; 2019 Sep; 35(9):1637-1649. PubMed ID: 31037473
[TBL] [Abstract][Full Text] [Related]
14. Right Heart End-Systolic Remodeling Index Strongly Predicts Outcomes in Pulmonary Arterial Hypertension: Comparison With Validated Models.
Amsallem M; Sweatt AJ; Aymami MC; Kuznetsova T; Selej M; Lu H; Mercier O; Fadel E; Schnittger I; McConnell MV; Rabinovitch M; Zamanian RT; Haddad F
Circ Cardiovasc Imaging; 2017 Jun; 10(6):. PubMed ID: 28592589
[TBL] [Abstract][Full Text] [Related]
15. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.
Allanore Y; Borderie D; Avouac J; Zerkak D; Meune C; Hachulla E; Mouthon L; Guillevin L; Meyer O; Ekindjian OG; Weber S; Kahan A
Arthritis Rheum; 2008 Jan; 58(1):284-91. PubMed ID: 18163505
[TBL] [Abstract][Full Text] [Related]
16. Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension.
Douwes JM; Roofthooft MT; Bartelds B; Talsma MD; Hillege HL; Berger RM
Int J Cardiol; 2013 Sep; 168(2):1370-7. PubMed ID: 23340486
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of prognosis and associated risk factors in pediatric idiopathic pulmonary arterial hypertension].
Liu Q; Zhang C; Li QQ; Zhu Y; Zhang D; Zhao WG; Gu H
Zhonghua Er Ke Za Zhi; 2018 Jan; 56(1):23-28. PubMed ID: 29342993
[No Abstract] [Full Text] [Related]
18. Right Heart Score for Predicting Outcome in Idiopathic, Familial, or Drug- and Toxin-Associated Pulmonary Arterial Hypertension.
Haddad F; Spruijt OA; Denault AY; Mercier O; Brunner N; Furman D; Fadel E; Bogaard HJ; Schnittger I; Vrtovec B; Wu JC; de Jesus Perez V; Vonk-Noordegraaf A; Zamanian RT
JACC Cardiovasc Imaging; 2015 Jun; 8(6):627-38. PubMed ID: 25981508
[TBL] [Abstract][Full Text] [Related]
19. Connective Tissue Disease-Associated Pulmonary Arterial Hypertension in Southern Taiwan: A Single-Center 10-Year Longitudinal Observation Cohort.
Wu CH; Lin CY; Hsu CH; Lin SH; Weng CT
Healthcare (Basel); 2021 May; 9(5):. PubMed ID: 34065585
[No Abstract] [Full Text] [Related]
20. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
